Cost-effective construction and renovation work with a focus on businesses, schools, and in-house developments

Asking price Price on request

Financial data

Turnover / Revenue €8,000,000.00

Description: Profitable family business active in general construction and renovation work. Company with an excellent reputation. Focus on quality, service, and flexibility with a solid B2B clientele

Organization: > 19 FTEs, stable and motivated team, qualified staff excelling in technical knowledge

Clientele: Mainly focused on companies, schools, and own developments. Returning clients

Financial: Highly profitable with turnover > EUR 8 million, EBITDA > EUR 500,000, completely debt-free

Reason for sale: No suitable family successor

Real estate: Owned by the company. Well-equipped buildings with modern offices, workshops, and warehouses located in an easily accessible industrial zone, including separate building land suitable for development. Market value > EUR 2.2 million (appraisal report available)

Price range: EUR 5 million for 100% of the shares, including real estate > EUR 2 million, rolling stock/machinery > EUR 1 million, and cash > EUR 1.5 million. Excellent value for money!

Number of employees
19
Real estate included
No
Translated from
Dutch
Disclaimer
Takeover market is not responsible for the content. Please check for accuracy and completeness.

Meer van deze overnamebemiddelaar

All company advertisements
High-performing pharmacy in Flemish Brabant
Vlaams-Brabant

DaVinci Corporate Finance is facilitating the sale of an established and highly successful pharmacy in Flemish Brabant. The pharmacy boasts an excellent central location, strong customer loyalty, and a solid financial track record.The pharmacy combines traditional pharmaceutical services with custom-compounded medications and a growing focus on prevention and lifestyle counseling. Operations are already largely automated and are supported by an experienced team of pharmacists. The business also offers ample parking in the immediate vicinity.Key Figures for 2025Revenue: approx. €3.0 millionAdjusted EBITDA: approx. €436kNormalized EBITDA margin: approx. 14.6%Revenue growth over the past few yearsEstablished local market position and recurring patient baseThe transaction primarily involves the transfer of 100% of the shares in the operating company. In addition, depending on the buyer’s interest, additional pharmaceutical licenses and the commercial real estate may be included in the transaction. An additional pharmacy business operated by the sellers is also negotiable.The current shareholders will provide for a thorough handover and onboarding period to ensure the continuity of the pharmacy.Investment HighlightsStrong, historically established position in the local marketRevenue of approximately €3.0 million with attractive profitabilityCentral and easily accessible locationLarge and loyal patient baseExperienced team consisting exclusively of pharmacistsAutomated operationsFurther growth opportunities through, among other things, additional services, digitization, and commercial activationFlexible transaction scope with real estate and additional permits as potential building blocksInterested?After signing a non-disclosure agreement, additional information can be provided to qualified prospective buyers.

Price Price on request
Liberal professions

Receive our newsletter

Leave your e-mail address and stay informed of our latest updates and offers. We will gladly keep you informed of new search results and relevant information.